Eye Health News and Research

Latest Eye Health News and Research

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

1 Nov 2010

Consumer Reports publishes survey on eyeglass retailers

Shopping for eyeglasses isn't easy, especially when frames can cost well over $200 a pair, even without the fancy add-ons and logos. But a Consumer Reports survey found that a great pair of eyeglasses doesn't have to break the bank.

1 Nov 2010

Catalyst’s CPP-115 improves retinal safety profile than vigabatrin

Catalyst Pharmaceutical Partners, Inc. today announced positive results from a series of CPP-115 preclinical safety and efficacy evaluations. CPP-115 was found to have a significantly improved retinal safety profile compared to vigabatrin.

1 Nov 2010

UCSD announces agreement with PHP to develop UC San Diego Proton Therapy and Research Center

Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.

1 Nov 2010

EHSI President seeks new medical technologies and investment opportunities in Poland

Emerging Healthcare Solutions President and CEO Cindy Morrissey is in Poland this week to seek out new medical technologies and investment opportunities for the company.

30 Oct 2010

CONCERTA improves handwriting performance in children with ADHD: Study

Data presented today at a major medical meeting include findings that demonstrate improved handwriting performance in children with Attention Deficit Hyperactivity Disorder (ADHD) when taking CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) compared to placebo.

30 Oct 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Shire plc the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(escitlopram) for Major Depressive Disorder (MDD).

29 Oct 2010

Research on Rictor protein may provide new molecular target for cancer treatment

The discovery that a protein called Rictor plays a key role in destroying a close cousin of the AKT oncogene could provide scientists with a new molecular target for treating certain cancers, including breast cancer. Described in the September 2010 issue of the journal Molecular Cell, the study was led by scientists at Beth Israel Deaconess Medical Center (BIDMC).

29 Oct 2010

ACADIA and BLS enter agreement to conclude pimavanserin collaboration

ACADIA Pharmaceuticals Inc. today announced that it has entered into an agreement with Biovail Laboratories International SRL ("BLS"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., pursuant to which ACADIA and BLS have agreed to conclude their previously established collaboration to develop and commercialize pimavanserin in the United States and Canada.

29 Oct 2010

cbm marks 10 millionth cataract surgery

Today's cataract surgery of Joyce Kaaya, 57, in Moshi, Tanzania symbolically marks the 10 millionth cataract surgery in cbm-supported programs throughout the world.

29 Oct 2010

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

QLT Inc. today announced expansion of the Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber Congenital Amaurosis (LCA) to include patients with Retinitis Pigmentosa (RP), a set of hereditary retinal diseases demonstrating clinical features similar to LCA.

28 Oct 2010

Candidates on health care offense, defense in final week before election

Candidates are in full campaign mode ahead of midterm elections that will likely spell out how the health law is implemented. The New York Times reports that some Democrats are playing defense after voting for health reform. They include Virginia Rep. Tom Perriello who is running against Republican state Sen. Robert Hurt.

28 Oct 2010

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

Scientists from deCODE genetics today publish in Nature the highest resolution recombination map of the human genome yet developed. Recombination is the reshuffling of the genome that occurs in the formation of eggs and sperm: we inherit one version of each chromosome from each of our parents, and create novel blends of the two that we pass on to our offspring.

28 Oct 2010

Diabetes threatens the eyesight of many unsuspecting Americans

Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam. As the number of people with Type 2 diabetes rises in the U.S., the CDC projects that the number of adults with diabetic retinopathy will double by the year 2050. Yet 90 percent of diabetic eye disease can be prevented simply by proper regular examinations and treatment and by controlling blood sugar.

27 Oct 2010

USAID announces LAUNCH: Health innovators

The U.S. Agency for International Development (USAID), NASA, NIKE, Inc. and the U.S. Department of State are pleased to announce those selected to participate in the LAUNCH: Health Forum. The innovators selected will participate in an event at NASA's Kennedy Space Center in Florida October 30-31, followed immediately by the launch of the Space Shuttle Discovery on November 1.

27 Oct 2010

Telehealth Monitoring System improves health outcomes in patients with chronic diseases

Patients with Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), Diabetes, and wounds are often treated and stabilized in a hospital setting then discharged to continue care at home under the supervision of a Certified Home Health Care Agency. Many high risk patients can now be monitored at home through a Telehealth Monitoring System.

27 Oct 2010

Dobkin technique delays brain damage in heart attack victims

After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it?

27 Oct 2010

Columbia University researchers to use IBM's streaming analytics to detect complications in brain injury

IBM today announced a new project in which researchers at Columbia University Medical Center will utilize IBM's streaming analytics technology to potentially detect severe complications in brain injured patients up to 48 hours earlier than traditional methods.

27 Oct 2010

LCA-Vision third quarter net loss decreases to $8.4 million

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three and nine months ended September 30, 2010.

26 Oct 2010

Eye Health News and Research

Latest Eye Health News and Research

Allergan third quarter diluted loss per share increases to $2.21

Consumer Reports publishes survey on eyeglass retailers

Catalyst’s CPP-115 improves retinal safety profile than vigabatrin

UCSD announces agreement with PHP to develop UC San Diego Proton Therapy and Research Center

EHSI President seeks new medical technologies and investment opportunities in Poland

CONCERTA improves handwriting performance in children with ADHD: Study

Merck reports $342 million net income for 2010 third quarter

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Research on Rictor protein may provide new molecular target for cancer treatment

ACADIA and BLS enter agreement to conclude pimavanserin collaboration

cbm marks 10 millionth cataract surgery

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

Candidates on health care offense, defense in final week before election

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

Diabetes threatens the eyesight of many unsuspecting Americans

USAID announces LAUNCH: Health innovators

Telehealth Monitoring System improves health outcomes in patients with chronic diseases

Dobkin technique delays brain damage in heart attack victims

Columbia University researchers to use IBM's streaming analytics to detect complications in brain injury

LCA-Vision third quarter net loss decreases to $8.4 million

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in